Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
about
Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation TherapyFive fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.Overview of radiation therapy for treating rectal cancer.Vaginal displacement during course of adjuvant radiation for cervical cancer: results from a prospective IG-IMRT study.Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapyAutomated generation of IMRT treatment plans for prostate cancer patients with metal hip prostheses: comparison of different planning strategies.Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer.A biological modeling based comparison of two strategies for adaptive radiotherapy of urinary bladder cancer.Kidney-Sparing Methods for Extended-Field Intensity-Modulated Radiotherapy (EF-IMRT) in Cervical Carcinoma Treatment.Dosimetric comparative study of 3 different postoperative radiotherapy techniques (3D-CRT, IMRT, and RapidArc) for II-III stage rectal cancer.Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy.Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.Predictors of late bowel toxicity using three different methods of contouring in patients undergoing post-operative radiation for cervical cancer.Craniocaudal tumour extension in uterine cervical cancer on MRI compared to histopathology.Radiation therapy oncology group gynecologic oncology working group: comprehensive resultsPractice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.Dosimetric comparison of axilla and groin radiotherapy techniques for high-risk and locally advanced skin cancerDosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancerThe predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation.Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.Anal cancer: are we making progress?Radiotherapy in the management of prostate cancer after radical prostatectomy.Sparing functional anatomical structures during intensity-modulated radiotherapy: an old problem, a new solution.Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer.Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer.Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancerEffect of a urinary catheter on seed position and rectal and bladder doses in CT-based post-implant dosimetry for prostate cancer brachytherapy.Implementation of intensity modulated radiotherapy for prostate cancer in a private radiotherapy service in Mexico.
P2860
Q28082745-8ADCBE9E-85F0-4801-A489-E6903137F477Q33637997-FD15E0AB-C528-4E2C-BA43-75F3D56498CAQ34136267-8C1DC6A0-44DA-4900-B040-AD9C48C3D38BQ34223248-9DC3EE6B-EE31-4828-82C1-66F981ADF647Q34267834-1C229DEB-53EB-496C-AFE8-8527B471F73AQ34324918-FB8A7695-2EF0-4CD4-A2E2-54DB079B0046Q34584811-07B56785-0DB7-48D9-8C8E-B364F49658E0Q34791747-DB1B6F82-AD79-4CD5-AC76-E564CE532F49Q34845036-4FD2B260-D624-46C3-8D67-A73C741F3690Q35500065-4D4003C8-00BA-41AC-9116-F95BEC59A9E5Q35943251-1ACA46D6-5279-40E1-9B71-DDAAC673A583Q35995755-B35DAF67-8EDA-4499-8C9C-F5D9F743214AQ36039660-63CD938C-3E5D-44A7-B567-88A416983B04Q36152873-E60E0DD0-C42A-4370-A015-1B5226BA9096Q36235721-85C36E21-6EC9-455E-90B6-1BBF0D10A743Q36383774-620924EC-5FED-4296-BD33-2A2D9AD7D772Q36384616-DC6D1E18-E85C-4F2B-B01E-27EBAFA849DBQ36550519-3E93FA9F-9E58-44D2-AA98-957DC271B5CDQ36571512-39B61ECA-9243-4D10-9F1C-5AFE638F48B1Q36730351-0D9CF679-C99F-4376-BBEC-88E8C997414CQ36835988-A7262A24-987A-4D49-B255-F95C0E1FA7FCQ37079068-18381246-5EB4-428F-9047-D87A17C1AE95Q37175139-7F624FDD-DEB1-468A-80D0-76850FCD817BQ37366354-DA580A72-204A-4397-BA00-9FEAD0A4EF05Q37419665-0FEDC8F8-9C1F-4BC7-AD44-5DFABF31D8ECQ37601093-44BAE260-5691-4248-8418-F7518FF65908Q38078283-8AB191A9-C85E-4027-B5CF-225E3019C405Q38104412-EBB8AD47-729E-485B-9D5F-3993D157B897Q38132448-2A69CF9E-D57F-4FD7-91BA-F3CC58057F34Q38401237-F26527C2-D7B8-4282-9DAF-F7D1D7DD99D2Q38616001-C48A7DFE-068A-44EB-B252-FEE4095D80DBQ38921996-587AD52A-255A-4C9F-86C9-AD0A177C34EBQ38982759-2DB7508E-8211-42B3-A269-1D85206180EAQ39456200-F769CDFD-9D93-4E65-8723-D5C165B54931Q40044229-C1492220-4415-4603-B4C8-E0D774AF842AQ40063703-35916FA5-5D03-4AB2-9B65-ECC27511968EQ40827296-9BE27B01-7711-42F1-BAED-444DA7E292CFQ40959922-81F5B854-EFC3-4986-846F-058DB1355711Q41115588-CAB48C61-2F16-40A8-8875-5E673DB1DB75Q41868843-0A455AE2-C66C-4D1A-8B3B-F593EA0B9188
P2860
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pelvic normal tissue contourin ...... gy Group consensus panel atlas
@en
Pelvic normal tissue contourin ...... y Group consensus panel atlas.
@nl
type
label
Pelvic normal tissue contourin ...... gy Group consensus panel atlas
@en
Pelvic normal tissue contourin ...... y Group consensus panel atlas.
@nl
prefLabel
Pelvic normal tissue contourin ...... gy Group consensus panel atlas
@en
Pelvic normal tissue contourin ...... y Group consensus panel atlas.
@nl
P2093
P2860
P50
P1476
Pelvic normal tissue contourin ...... gy Group consensus panel atlas
@en
P2093
Anthony Zietman
Anuja Jhingran
Christopher Willett
Colleen Lawton
David Gaffney
Elizabeth O'Meara
H Joseph Barthold
Howard Sandler
Issam El Naqa
Janice Ryu
P2860
P304
P356
10.1016/J.IJROBP.2012.01.023
P407
P577
2012-04-06T00:00:00Z